The burden of atherosclerosis in Portugal

Detalhes bibliográficos
Autor(a) principal: Costa, J
Data de Publicação: 2020
Outros Autores: Alarcão, J, Araujo, F, Ascenção, R, Caldeira, D, Fiorentino, F, Gil, V, Gouveia, M, Lourenço, F, Mello E Silva, A, Sampaio, F, Vaz-Carneiro, A, Borges, M
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.26/34023
Resumo: Aims: This paper sought to estimate the burden of disease attributable to atherosclerosis in mainland Portugal in 2016. Methods and results: The burden of atherosclerosis was measured in disability-adjusted life years (DALY) following the latest 2010 Global Burden of Disease (GBD) methodology. DALYs were estimated as the sum of years of life lost (YLL) with years lived with disability (YLD). The following clinical manifestations of atherosclerosis were included: ischemic heart disease (IHD) (including acute myocardial infarction (AMI), stable angina, and ischemic heart failure (IHF)), ischemic cerebrovascular disease (ICVD) and peripheral arterial disease (PAD). YLL were estimated based on all-cause mortality data for the Portuguese population and mortality due to IHD, ICVD and PAD for the year 2016 sourced from national statistics. Standard life expectancy was sourced from the GBD study. YLD corresponded to the product of the number of prevalent cases by an average disability weight (DW) for all possible combinations of disease. Prevalence data for the different clinical manifestations of atherosclerosis were sourced from epidemiological studies. DW were sourced from the published literature. In 2016, 15,123 deaths were attributable to atherosclerosis, which corresponded to 14.3% of overall mortality in mainland Portugal. DALYs totaled 260,943, 75% due to premature death (196,438 YLL) and 25% due to disability (64,505 YLD). Conclusion: Atherosclerosis entails a high disease burden to society. A large part of this burden would be avoidable if evidence-based effective and cost-effective interventions targeting known risk factors, from prevention to treatment, were implemented.
id RCAP_bddefaacffed03f40951c235d4931132
oai_identifier_str oai:comum.rcaap.pt:10400.26/34023
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The burden of atherosclerosis in PortugalAteroscleroseCusto da DoençaAtherosclerosisCost of IllnessAims: This paper sought to estimate the burden of disease attributable to atherosclerosis in mainland Portugal in 2016. Methods and results: The burden of atherosclerosis was measured in disability-adjusted life years (DALY) following the latest 2010 Global Burden of Disease (GBD) methodology. DALYs were estimated as the sum of years of life lost (YLL) with years lived with disability (YLD). The following clinical manifestations of atherosclerosis were included: ischemic heart disease (IHD) (including acute myocardial infarction (AMI), stable angina, and ischemic heart failure (IHF)), ischemic cerebrovascular disease (ICVD) and peripheral arterial disease (PAD). YLL were estimated based on all-cause mortality data for the Portuguese population and mortality due to IHD, ICVD and PAD for the year 2016 sourced from national statistics. Standard life expectancy was sourced from the GBD study. YLD corresponded to the product of the number of prevalent cases by an average disability weight (DW) for all possible combinations of disease. Prevalence data for the different clinical manifestations of atherosclerosis were sourced from epidemiological studies. DW were sourced from the published literature. In 2016, 15,123 deaths were attributable to atherosclerosis, which corresponded to 14.3% of overall mortality in mainland Portugal. DALYs totaled 260,943, 75% due to premature death (196,438 YLL) and 25% due to disability (64,505 YLD). Conclusion: Atherosclerosis entails a high disease burden to society. A large part of this burden would be avoidable if evidence-based effective and cost-effective interventions targeting known risk factors, from prevention to treatment, were implemented.Repositório ComumCosta, JAlarcão, JAraujo, FAscenção, RCaldeira, DFiorentino, FGil, VGouveia, MLourenço, FMello E Silva, ASampaio, FVaz-Carneiro, ABorges, M2020-11-09T23:20:01Z2020-09-182020-09-18T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.26/34023engEur Heart J Qual Care Clin Outcomes . 2020 Sep 18;qcaa06010.1093/ehjqcco/qcaa060info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-25T04:46:17Zoai:comum.rcaap.pt:10400.26/34023Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:09:32.345135Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The burden of atherosclerosis in Portugal
title The burden of atherosclerosis in Portugal
spellingShingle The burden of atherosclerosis in Portugal
Costa, J
Aterosclerose
Custo da Doença
Atherosclerosis
Cost of Illness
title_short The burden of atherosclerosis in Portugal
title_full The burden of atherosclerosis in Portugal
title_fullStr The burden of atherosclerosis in Portugal
title_full_unstemmed The burden of atherosclerosis in Portugal
title_sort The burden of atherosclerosis in Portugal
author Costa, J
author_facet Costa, J
Alarcão, J
Araujo, F
Ascenção, R
Caldeira, D
Fiorentino, F
Gil, V
Gouveia, M
Lourenço, F
Mello E Silva, A
Sampaio, F
Vaz-Carneiro, A
Borges, M
author_role author
author2 Alarcão, J
Araujo, F
Ascenção, R
Caldeira, D
Fiorentino, F
Gil, V
Gouveia, M
Lourenço, F
Mello E Silva, A
Sampaio, F
Vaz-Carneiro, A
Borges, M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Comum
dc.contributor.author.fl_str_mv Costa, J
Alarcão, J
Araujo, F
Ascenção, R
Caldeira, D
Fiorentino, F
Gil, V
Gouveia, M
Lourenço, F
Mello E Silva, A
Sampaio, F
Vaz-Carneiro, A
Borges, M
dc.subject.por.fl_str_mv Aterosclerose
Custo da Doença
Atherosclerosis
Cost of Illness
topic Aterosclerose
Custo da Doença
Atherosclerosis
Cost of Illness
description Aims: This paper sought to estimate the burden of disease attributable to atherosclerosis in mainland Portugal in 2016. Methods and results: The burden of atherosclerosis was measured in disability-adjusted life years (DALY) following the latest 2010 Global Burden of Disease (GBD) methodology. DALYs were estimated as the sum of years of life lost (YLL) with years lived with disability (YLD). The following clinical manifestations of atherosclerosis were included: ischemic heart disease (IHD) (including acute myocardial infarction (AMI), stable angina, and ischemic heart failure (IHF)), ischemic cerebrovascular disease (ICVD) and peripheral arterial disease (PAD). YLL were estimated based on all-cause mortality data for the Portuguese population and mortality due to IHD, ICVD and PAD for the year 2016 sourced from national statistics. Standard life expectancy was sourced from the GBD study. YLD corresponded to the product of the number of prevalent cases by an average disability weight (DW) for all possible combinations of disease. Prevalence data for the different clinical manifestations of atherosclerosis were sourced from epidemiological studies. DW were sourced from the published literature. In 2016, 15,123 deaths were attributable to atherosclerosis, which corresponded to 14.3% of overall mortality in mainland Portugal. DALYs totaled 260,943, 75% due to premature death (196,438 YLL) and 25% due to disability (64,505 YLD). Conclusion: Atherosclerosis entails a high disease burden to society. A large part of this burden would be avoidable if evidence-based effective and cost-effective interventions targeting known risk factors, from prevention to treatment, were implemented.
publishDate 2020
dc.date.none.fl_str_mv 2020-11-09T23:20:01Z
2020-09-18
2020-09-18T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/34023
url http://hdl.handle.net/10400.26/34023
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur Heart J Qual Care Clin Outcomes . 2020 Sep 18;qcaa060
10.1093/ehjqcco/qcaa060
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133343382503425